Tenecteplase (0.25mg/kg)

DRUG4 trials

Sponsors

Centre Hospitalier Sud Francilien, Beijing Tiantan Hospital, First Hospital of China Medical University

Conditions

Acute Distal Vessel Occlusion StrokeMedium Vessel OcclusionsStrokeStroke, Ischemic

Phase 3

Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND

RecruitingNCT06954155

Beijing Tiantan HospitalStroke

Start: 2025-05-30End: 2027-05-30Target: 330Updated: 2026-04-01

Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke

RecruitingNCT07047014

Beijing Tiantan HospitalMedium Vessel Occlusions, Stroke, Ischemic

Start: 2025-07-30End: 2027-06-30Target: 596Updated: 2026-04-01

Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window

Not yet recruitingNCT07476898

First Hospital of China Medical UniversityStroke

Start: 2026-03-01End: 2028-08-01Target: 864Updated: 2026-03-17

Unknown Phase

Early Recanalization After Intravenous Thrombolysis With Tenecteplase Versus Alteplase in Distal Vessel Occlusion Strokes

CompletedNCT05635786

Centre Hospitalier Sud FrancilienAcute Distal Vessel Occlusion Stroke

Start: 2023-01-02End: 2024-11-21Updated: 2025-03-13